Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

Healthpeak Properties, Inc.

DOCNYSE
Wall Street Score · overall investment28/100
$19.02USD$-0.34 (-1.76%)
Company website www.healthpeak.com
Headquarters4600 South Syracuse Street, Denver, CO, 80237, US
Financial statement currencyUSD · no FX conversion applied
Real Estate · REIT - Healthcare Facilities
Price updated todayFinancials updated Oct 23, 2026

DOC · Price history

Price at last available close

$19.02

−$1.08 (-5.37%) 1M

2026-10-27

Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.

Company & revenue

About Healthpeak Properties, Inc.

Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.

Who they are

Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.

How they make money

Healthpeak Properties, Inc. operates as a real estate investment trust (REIT) that generates revenue primarily through the ownership, operation, and development of healthcare-related real estate. The company leases its properties to healthcare providers and research institutions, collecting rental income under long-term contractual agreements while managing property-level operational costs.

Products & services

The company provides real estate infrastructure for healthcare discovery and delivery, specifically focusing on outpatient medical facilities, life science laboratory spaces, and continuing care retirement communities (CCRCs).

Brands & revenue mix

No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.

Product / operating segments

No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.

Geographic revenue

No reconciled geographic revenue breakdown was confirmed for the current research period.

Customer types

Customer concentration

The company's revenue is derived from a diverse base of tenants in the healthcare sector; no single tenant accounts for a majority of total revenue as of the fiscal year ended December 31, 2025.

Suppliers, materials & equipment

  • Property management and maintenance service providers — Various third-party vendors providing facility maintenance, security, and property management services.Source

Strengths

  • Diversified portfolio across outpatient medical, lab, and CCRC segmentsSource
  • Strategic focus on high-barrier-to-entry healthcare real estate marketsSource

Risks

  • Tenant credit risk and potential for operator financial distressSource
  • Sensitivity to interest rate fluctuations and capital market conditionsSource
  • Regulatory changes affecting healthcare reimbursement and government fundingSource

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

28

Poor

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

31

Poor

Financial Strength

32

Business Quality / Moat

28

Management

17

Growth Quality

36

Risk / Durability

54

Weak Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

28

Avoid

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

35/100

Building Historical Record

Model Score 35/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.

At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.

The model outlook is currently cautious.

What we like
  • •Recent buyback activity is present
What to watch
  • •Elevated debt risk
  • •Valuation is a weaker part of the current profile
  • •Revenue fundamentals are weak
  • •Debt / balance-sheet profile needs attention

Company-specific research

Questions worth answering for DOC

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •Can DOC maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • •Is DOC's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • •Is DOC's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • •What future growth or profitability would be needed to justify DOC's current valuation?
Elevated debt risk
Business analysis: 15 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

28

0–100 · Poor

Opportunity Score

28

0–100 · Poor

Market Cap

$13.11B

P/E Ratio

55.0

EPS

$0.35

52-Week High

$22.95

52-Week Low

$15.70

Beta

0.99

Intrinsic Value

$10.71

Analyst Target

$22.00

Shares Outstanding

696.0M

Total Revenue

$2.95B

Total Debt

$10.32B

Dividend Yield (TTM)

5.88%

View dividend history

Liquidation Value / Share

$13.65

Estimated net asset value per share

Dividend / Share (TTM)

$1.12

Trailing 12 months by ex-date; not a forecast

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
42/ 100
+14 pts / 5d

Weakening momentum

5D +1.4% · 20D -5.5% · RSI 55 · Price vs 20D avg +0.1%
Volatility
32/ 100
+10 pts / 5d

Low movement

20D realized vol 30.1% · 60D 22.7% · Acceleration 1.32x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for DOC

Detected from reported data — verify before acting.

Dividend history reported

Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.

Historical repurchase activity

Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.

Elevated debt risk

Total debt is at least one year of revenue • Interest coverage is below 2x • Cash covers less than 20% of total debt

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on DOC.

Potential upside factors

  • +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
  • +Diversified portfolio across outpatient medical, lab, and CCRC segments.
  • +Strategic focus on high-barrier-to-entry healthcare real estate markets.
  • +Positive free cash flow may provide capacity to invest in growth.

Potential downside factors

  • −Debt risk (elevated): Total debt is at least one year of revenue.
  • −Interest coverage is below 2x.
  • −Cash covers less than 20% of total debt.
  • −Tenant credit risk and potential for operator financial distress.

These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Weak28/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Poor

28

Tap for breakdown →

Poor

26

Debt Cost2.9%
Debt Reduction YoY-15.7%
Debt / Equity1.39x

Tap for breakdown →

Poor

23

Revenue YoY4.5%
Revenue CAGR13.8%
Net Margin8.6%

Tap for breakdown →

Fair

55

Asset Growth YoY2.0%
Liquidation/Share$13.65
Net Assets/MCap0.86x

Tap for breakdown →

Poor

13

Earnings Yield1.9%
Buyback Yield0.7%
Debt Cost2.9%

Tap for breakdown →

Poor

17

ROIC3.0%
ROE3.2%
ROA1.2%

Tap for breakdown →

Poor

28

EPS Growth-48.5%
FCF/Share Growth3.4%
Rev/Share Growth3.2%

Tap for breakdown →

Poor

0

Intrinsic Value$10.71
Value Reference$6.42
MOS-79.8%

Tap for breakdown →

Poor

26

Revenue23
Moat28
Valuation0

Tap for breakdown →

Poor

0

MOS %-79.8%
Value Reference$6.42
Deep Discount Reference$4.28

Tap for breakdown →

Fair

54

Interest Coverage1.8x
ROIC3.0%
FCF Yield9.4%

Tap for breakdown →

Weak

42

Financial54
Valuation0
Debt26

Tap for breakdown →

Strong

73

Survival Years12.9 yrs
Current Ratio1.09x
FCF Margin44.4%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

8 historical score records available

Previous Score

27

Oct 1, 2026

Change

+0.2

points

Current Score

28

Oct 23, 2026

Category Changes

Revenue+0.2
Debt0
Assets+1.0
Capital+1.0
Management0
Moat0
Valuation0
Buffett+0.2

DOC increased 0.2 points because overall fundamentals improved.

Projected Score

Projected Score

32

Projected Change

+4.4 points

Preliminary comparable-period financial changes suggest improvement of approximately 4.4 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Overvalued

Current Price

$19.02

Model Intrinsic Value

$10.71

Difference

+$8.31

+77.6% vs IV

Margin of Safety

-77.6%

UndervaluedFair ValueOvervalued
Value Reference: $6.42
Deep Discount Reference: $4.28

Financial Charts

Revenue

201420152016201720182019202020212022202320242025$0$750M$1.5B$2.3B$3.0B

Additional Metrics

Operating Cash Flow

201520172019202120232025$0$350M$700M$1.1B$1.4B

Total Debt

201520172019202120232025$0$3.0B$6.0B$9.0B$12.0B

Total Assets

201520172019202120232025$0$5.5B$11.0B$16.5B$22.0B

Net Margin %

No data
Monetary values in USD. Share counts in raw units.

Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.

Line ItemTTM2025202420232022202120202019201820172016
Revenue$2.95B$2.82B$2.70B$2.18B····························
Cost of Revenue$2.88B$2.19B$1.07B$902.1M····························
Gross Profit$74.7M$634.5M$1.63B$1.28B····························
Research & Development$0.00$0.00$0.00$0.00····························
SG&A Expenses$90.6M$90.4M$97.2M$95.1M····························
Operating Expenses-$444.7M$90.4M$1.15B$845.0M····························
EBITDA$1.75B$1.44B$1.61B$1.27B····························
Operating Income$519.5M$544.1M$471.2M$433.9M····························
Interest Expense$337.0M$305.2M$280.4M$200.3M····························
Income Before Tax$278.5M$110.3M$271.7M$325.1M····························
Income Tax Expense$3.7M$9.3M$4.3M-$9.6M····························
Net Income$253.7M$71.3M$243.1M$306.0M····························
Basic EPS$0.35$0.10$0.36$0.56····························
Basic Shares690M696M676M547M····························
Diluted Shares690M696M676M547M····························
Upgrade to Premium for up to 10 annual periods, where available.
Upgrade to Premium

Earnings Summary

Estimated earnings date:Nov 2, 2026
Estimated EPS: $0.06Estimated revenue: $748.4M
Jun 30, 2026Q2FY2026

Revenue

$771.6M

Estimate unavailable.

Revenue Beat/Miss

Not available (no estimate stored)

EPS

$0.08

Estimate unavailable.

EPS Beat/Miss

Not available (no estimate stored)

Debt Change

+10.4%

Cash Change

+1719.0%

Margin Change

+3.6 pp

Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.

Financial Changes Since Prior Period

What Improved

  • Margins expanded
  • Cash position grew

What Weakened

  • Debt increased

Potential Score Impact

Positive indicators included revenue growth, EPS growth, cash levels, net income margin. Pressure indicators included debt levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.

Stored Earnings Analysis

Revenue increased 11.1%. EPS increased 76.2%. Cash increased 1719.0%. Total debt increased 10.4%. Net income margin improved by 3.6 percentage points.

Earnings-Call Transcript

Earnings-call transcript analysis is not currently available.

These results may influence future scores when the next evaluation is completed.

Upgrade to Premium to unlock all earnings history.View plans
Earnings data: 120 days ago · Stale

Insider Activity

Guru / Smart Money

Guru Score

7

Smart Money

7

Number of Gurus

1

Total Guru Value

Avg Portfolio Weight

Largest Holder

Largest Holder %

New Positions

Increased Positions

Reduced Positions

Exited Positions

Net Guru Sentiment

Loading data...

Short Interest

Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.

Dividend History

Log in to view dividend history.

Conservative Projected Values

3 Years

$———.——

Premium

5 Years

$———.——

Premium

10 Years

$———.——

Premium

Conservative Projection Rate

——%

Premium

Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.

Conservative Projected Values

Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.

Start 7-Day Free Trial

Historical Outperformance Record

Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.

Start 7-Day Free Trial

Historical Trends

8 historical records
Jul 21, 26Jul 23, 26Aug 12, 26Sep 3, 26Sep 6, 26Sep 21, 26Oct 1, 26Oct 23, 260255075100

Historical Score Chart

3 of 8 records shown
3 historical score records are shown. Start your seven-day free trial to unlock 5 more records and the complete score history.Start Free Trial

Wall Street Score

Sep 21, 26Oct 1, 26Oct 23, 260255075100

Debt Score

Sep 21, 26Oct 1, 26Oct 23, 260255075100

Revenue Score

Sep 21, 26Oct 1, 26Oct 23, 260255075100

Asset Score

Sep 21, 26Oct 1, 26Oct 23, 260255075100

Capital Score

Sep 21, 26Oct 1, 26Oct 23, 260255075100

Management Score

Sep 21, 26Oct 1, 26Oct 23, 260255075100

Moat Score

Sep 21, 26Oct 1, 26Oct 23, 260255075100

Valuation Score

Sep 21, 26Oct 1, 26Oct 23, 260255075100

Buffett Score

Sep 21, 26Oct 1, 26Oct 23, 260255075100

Intrinsic Value

Sep 21, 26Oct 1, 26Oct 23, 26$8.00$9.00$10.00$11.00$12.00

Value Reference

Sep 21, 26Oct 1, 26Oct 23, 26$4.00$5.00$6.00$7.00$8.00

Margin of Safety %

Sep 21, 26Oct 1, 26Oct 23, 26-0.9%-0.9%-0.8%-0.8%-0.8%

Related Companies

REIT - Healthcare Facilities

CTRE

CareTrust REIT, Inc.

55Fair
$36.98View

LTC

LTC Properties, Inc.

53Fair
$43.96View

OHI

Omega Healthcare Investors, Inc.

50Fair
$46.13View

NHI

National Health Investors, Inc.

49Weak
$67.06View

XRN

Chiron Real Estate Inc.

45Weak
$28.83View

STRW

Strawberry Fields REIT, Inc.

40Weak
$12.75View

News

Rumor Mill · DOC

Corporate developments & opportunities

Explore market →

No reviewed developments match this filter.

Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksBest growth stocksBest healthcare stocksTop REITsHow Wall Street Score worksHow to analyze a stockUnderstanding financial health

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial